BVS BIOVENTUS CLASS A

Health Care · Russell 2000

Next earnings: not announced yet

What 7 analyst firms say about BIOVENTUS CLASS A: their latest ratings, price targets and how far the stock is from them. How it works

10.61 USD−0.07 (−0.66%) today

Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+58.3%to the avg target 16.80 USD+6.19 USD

Buy 6 · Hold 1 · Sell 0

7 rated views · 8 analyst/firm records · 7 firms

Latest report28 Oct 2026avg report date 1 Aug

Target rangePrice is below every target

now 10.61

Radar score

Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8079
Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8065

Recent analyst activity · last 90 days

Our tracked history has 5 reports on BVS from 4 analyst firms in the last 90 days (7 firms in the past year).

Comparing each firm's latest target with its previous one: 1 lowered it, 1 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Canaccord Genuity lowered its target from $19.00 (set 17 Aug 2026) to $18.00 on 3 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

Firm	Analyst	Latest rating	Report date	Latest target (USD)
Barrington Research	Michael J Petusky	Buy	28 Oct 2026	18.00 USD
Canaccord Genuity	Caitlin Cronin	Buy	17 Aug 2026	19.00 USD
Canaccord Genuity	Caitlin Roberts	Buy	16 Jun 2026	Conflicting reports · excluded
Cantor Fitzgerald	Sarah James	Buy	17 Aug 2026	15.00 USD
Cjs Securities	Unnamed analyst	Buy	27 Mar 2026	14.00 USD
Craig-Hallum	Chase Knickerbocker	Buy	6 Aug 2026	18.00 USD
Weiss Ratings	Unnamed analyst	—	8 Oct 2026	—
Data feed RESEARCH	Research Team	Hold	20 Mar 2026	—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:13 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.